Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114631) titled 'Role of the CHDH/p-CREB Axis in Regulating Breast Cancer Pathogenesis' on Dec. 16, 2025.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Dalian Women and Children's Medical Group

Condition: Breast cancer

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-01-01

Target Sample Size: Observation group:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=298532

Disclaimer: Curated by HT Syndication....